Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,030 total articles
Cerus (CERS) is trading below recent moving averages after a healthy run from its 2025 lows. With a market cap near $403M, positive free cash flow, and rising short interest, the setup favors a mid-term swing long. Entry at $2.05, stop at $1.80, target $3.00 — plan for roughly 45 trading days and size to risk tolerance.
SSR Mining is a diversified precious metals producer trading at roughly $6.5B market cap with improving production guidance, a $300M buyback, low leverage and positive free cash flow. A re-rating driven by Copler restart prospects, accelerating gold prices and reduced public float is a reasonable base case. This trade lays out an entry, stop and ta…
Micron ($MU) is benefitting from an accelerating AI memory supercycle. The stock is trading at $400.50 with a market cap around $451B, healthy cash flows, and tight market technicals that favor a tactical long. This trade targets the recent 52-week high near $455 while keeping a disciplined stop below the 50-day technical band.
CTO Realty Growth (CTO) is a small-cap REIT ($634M market cap) trading near $19.48 with a ~7.7% dividend yield, a P/B of ~1.13 and a portfolio concentrated in the Southeast. Recent 2025-26 acquisition activity ($165.9M invested at a 9.0% initial cash yield, plus the $81.6M Palms Crossing purchase on 03/02/2026) and leasing wins lift cash flow visib…
Circle (CRCL) just posted blowout Q4 results, proving stablecoins can be a high-growth, profitable business. With USDC circulation north of $75 billion, reserve income surging and a product roadmap that connects to the AI payments wave, we upgrade CRCL to Buy. Trade plan included with entry at $108.30, stop at $92.00 and a $160.00 target over a 180…
Microsoft remains the safest, highest-leverage way to own the enterprise AI transition. Absent recent financial line items for this note, the trade rests on durable cloud economics, strong free cash flow potential, and accelerating AI monetization. Enter around $470.00, stop $420.00, target $560.00 over a long-term 180 trading day horizon; size acc…
Inter appears to be in an active scaling phase: expanding product distribution, building recurring revenue streams, and pushing unit economics toward profitability. With limited public snapshot data available, this trade favors a scaled long entry that respects competition, execution risk and the lack of near-term financial disclosure. Targeted ups…
Royal Gold (RGLD) is a high-quality precious-metals royalty and streaming company that offers leveraged exposure to gold prices with low operating leverage. The stock has pulled back from its January highs and sits near technical support while fundamentals and deal activity continue to support the story. This trade idea proposes a mid-term swing bu…
Sabesp's privatization has removed a major overhang and professionalized management, making the stock a steadier regulated-utility play. The asymmetry that attracted risk-tolerant buyers post-privatization has narrowed; this trade targets a measured upside while protecting capital with a tight stop. Trade plan balances income-style stability with e…
BAB is a taxable municipal bond ETF offering a 4.12% yield and tight trading range near its 52-week high. Technicals show constructive momentum, and distributions are current. We lay out a mid-term trade with a specific entry, stop and target, plus catalysts and a balanced risk framework.
Goodyear (GT) is cheap on several enterprise multiples after a string of operational headwinds. Recent asset sales and the 'Goodyear Forward' program create a credible line of sight to improved margins and cash generation. This trade idea lays out a mid-term long with precise entry, stop and target calibrated to current technicals and the company's…
Bath & Body Works is trading at bargain multiples relative to its cash-generation ability. With free cash flow of $946M, an EV/EBITDA of 5.7 and a P/E near 6.7, the market has overly penalized BBWI for a failed adjacency strategy and short-term earnings misses. This trade idea upgrades the stock to a buy for a mid-term rebound, with a precise entry…
Allianz's 2025 performance and balance-sheet strength justify a renewed Buy. We lay out a trade with clear entry, stop and target levels tied to capital and operating catalysts while flagging regulatory, macro and execution risks.
Mitek Systems operates one of the clearest durable niches in fintech: mobile capture and identity verification. With roughly 50% penetration at U.S. banks, positive cash flow and a sub-$700M market cap, MITK is priced for steady growth. This trade idea lays out an entry at $15, a $19 target aligned with recent analyst work, and a $13 stop, with a l…
Relay Therapeutics' zovegalisib just cleared a major regulatory hurdle with FDA Breakthrough Therapy designation, validating clinical benefit signals and compressing timelines. With a market cap around $1.82B, bullish technicals and heavy short interest, this is a high-reward, high-risk mid-term trade aiming to capture a re-rating on upcoming data …
CoreWeave reported blistering revenue growth but stunned markets with a $30-35B capex plan for 2026 and stretched balance-sheet metrics. With operating losses, negative free cash flow of $7.25B, and debt levels implied by a 6.48 debt-to-equity ratio, this is a high-conviction, mid-term short trade set for 45 trading days. Trade size should be limit…
Woodside is transitioning from build-out to cash generation. Recent offtakes for its Louisiana LNG project and incremental long-term deals (Uniper, BOTAŞ) plus a 4.65% yield make a disciplined long entry attractive over the next 45 trading days. Technicals are hot — so size accordingly and use a clear stop.
Abercrombie & Fitch (ANF) is trading near $96 with strong cash flow, a lean balance sheet and an EV/EBITDA around 4.3. Fundamentals show high ROE (≈39.6%) and free cash flow of $384.5M, implying the stock is priced for modest growth. This trade idea argues for a long position sized prudently, with an entry at $96.00, stop at $85.00 and target at $1…
Berkshire Hathaway looks reasonably priced at roughly $487.50 with a P/E near 15.7, a modest P/B of ~1.5 and a near‑record cash war chest of $373.3B. Given the new leadership under Greg Abel and the company’s diversified earnings streams, a measured long position offers attractive asymmetry. Trade plan: enter at $487.50, target $540.00, stop $455.1…
Yancoal Australia sold off after FY2025 results disappointed expectations. We view the pullback as a buying opportunity: the company's asset base, cash generation profile and exposure to a recovering seaborne coal cycle provide asymmetric upside over the next 180 trading days, while careful risk management limits downside.
Carnival (CCL) offers a pragmatic income trade: a modest current yield, below-market valuation (P/E ~14), and meaningful free cash flow ($2.6B) support a dividend-focused long trade. Technicals are soft but manageable; use a conservative stop and target near the 52-week high for a low-risk, income-oriented position over the next 180 trading days.
UroGen (URGN) recently re-rated as ZUSDURI builds clinical credibility for treating recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC). With a market cap near $980M, durable efficacy data and an experienced commercialization push, ZUSDURI has the potential to replace TURBT in specific patient cohorts, supporting upsid…
USANA Health Sciences (USNA) trades at a valuation that looks disconnected from its balance-sheet strength and recent top-line momentum. With no debt, positive free cash flow ($18.7M last reported), an EV/EBITDA of ~3.0 and a market cap around $355M, USNA offers a low-leverage way to play recovery in the functional supplements market. This trade id…
Antero Midstream (AM) is trading near its 52-week highs on durable free cash flow, an accretive $1.1B HG Mid acquisition and management guidance for higher adjusted EBITDA and FCF in 2026. The combination of predictable midstream cash generation, balance-sheet improvement and active capital returns makes a tactical long attractive over a 180-tradin…
Cushman & Wakefield (CWK) is a leveraged but cash-generative commercial real estate services firm where valuation and free cash flow offer an asymmetric trade setup today. The recent lawsuit headline has injected volatility, but fundamentals - $293M in free cash flow, EV/EBITDA ~9, and EV/FCF in the mid-teens - argue for a long-biased, risk-defined…
